These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25155481)

  • 1. Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease.
    DeLong MR; Huang KT; Gallis J; Lokhnygina Y; Parente B; Hickey P; Turner DA; Lad SP
    JAMA Neurol; 2014 Oct; 71(10):1290-5. PubMed ID: 25155481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor.
    Verla T; Marky A; Farber H; Petraglia FW; Gallis J; Lokhnygina Y; Parente B; Hickey P; Turner DA; Lad SP
    J Clin Neurosci; 2015 May; 22(5):872-6. PubMed ID: 25669119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and patterns of secondary complications in surgical inpatients.
    Wakeam E; Hyder JA; Jiang W; Lipsitz SA; Finlayson S
    JAMA Surg; 2015 Jan; 150(1):65-73. PubMed ID: 25472013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of risk factors for seizures after deep brain stimulation surgery. Clinical article.
    Pouratian N; Reames DL; Frysinger R; Elias WJ
    J Neurosurg; 2011 Aug; 115(2):310-5. PubMed ID: 21548744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease.
    Mikos A; Pavon J; Bowers D; Foote KD; Resnick AS; Fernandez HH; Thomas P; Garvan C; Roy A; Okun MS
    Parkinsonism Relat Disord; 2010 Jun; 16(5):324-8. PubMed ID: 20202888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Bilateral vs. Staged Unilateral Deep Brain Stimulation (DBS) in Parkinson's Disease in Patients Under 70 Years of Age.
    Petraglia FW; Farber SH; Han JL; Verla T; Gallis J; Lokhnygina Y; Parente B; Hickey P; Turner DA; Lad SP
    Neuromodulation; 2016 Jan; 19(1):31-7. PubMed ID: 26568568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Adverse Outcomes After Deep Brain Stimulation Treatment in Patients with Parkinson Disease.
    Hu K; Moses ZB; Hutter MM; Williams Z
    World Neurosurg; 2017 Feb; 98():365-374. PubMed ID: 27826085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and Long-Term Outcomes of Deep Brain Stimulation in Patients 70 Years and Older with Parkinson Disease.
    Mathkour M; Garces J; Scullen T; Hanna J; Valle-Giler E; Kahn L; Arrington T; Houghton D; Lea G; Biro E; Bui CJ; Sulaiman OA; Smith RD
    World Neurosurg; 2017 Jan; 97():247-252. PubMed ID: 27297246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.
    Okun MS; Tagliati M; Pourfar M; Fernandez HH; Rodriguez RL; Alterman RL; Foote KD
    Arch Neurol; 2005 Aug; 62(8):1250-5. PubMed ID: 15956104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection related to deep brain stimulation in patients with Parkinson disease: Clinical characteristics and risk factors.
    Kim MS; Jeong JS; Ryu HS; Choi SH; Chung SJ
    J Neurol Sci; 2017 Dec; 383():135-141. PubMed ID: 29246601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae.
    Gologorsky Y; Ben-Haim S; Moshier EL; Godbold J; Tagliati M; Weisz D; Alterman RL
    Neurosurgery; 2011 Aug; 69(2):294-9; discussion 299-300. PubMed ID: 21389886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of unfavorable outcomes following deep brain stimulation for movement disorders and the effect of hospital case volume on outcomes: an analysis of 33, 642 patients across 234 US hospitals using the National (Nationwide) Inpatient Sample from 2002 to 2011.
    Kalakoti P; Ahmed O; Bollam P; Missios S; Wilden J; Nanda A
    Neurosurg Focus; 2015 Jun; 38(6):E4. PubMed ID: 26030704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
    Morishita T; Hilliard JD; Okun MS; Neal D; Nestor KA; Peace D; Hozouri AA; Davidson MR; Bova FJ; Sporrer JM; Oyama G; Foote KD
    PLoS One; 2017; 12(9):e0183711. PubMed ID: 28902876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of common complications in deep brain stimulation surgery: management and avoidance.
    Fenoy AJ; Simpson RK
    J Neurosurg; 2014 Jan; 120(1):132-9. PubMed ID: 24236657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.